Background: Prehabilitation seeks to optimize patient health before surgery to improve outcomes. Randomized controlled trials (RCTs) have been conducted on prehabilitation, however an updated synthesis of this evidence is required across General Surgery to inform potential Supplementary discipline‐level protocols. Accordingly, this systematic review of RCTs aimed to evaluate the use of prehabilitation interventions across the discipline of General Surgery.Methods: This study was registered with PROSPERO (CRD42023403289), and adhered to PRISMA 2020 and SWiM guidelines. PubMed/MEDLINE and Ovid Embase were searched to 4 March 2023 for RCTs evaluating prehabilitation interventions within the discipline of General Surgery. After data extraction, risk of bias was assessed using the Cochrane RoB 2 tool. Quantitative and qualitative data were synthesized and analysed. However, meta‐analysis was precluded due to heterogeneity across included studies.Results: From 929 records, 36 RCTs of mostly low risk of bias were included. 17 (47.2%) were from Europe, and 14 (38.9%) North America. 30 (83.3%) investigated cancer populations. 31 (86.1%) investigated physical interventions, finding no significant difference in 16 (51.6%) and significant improvement in 14 (45.2%). Nine (25%) investigated psychological interventions: six (66.7%) found significant improvement, three (33.3%) found no significant difference. Five (13.9%) investigated nutritional interventions, finding no significant difference in three (60%), and significant improvement in two (40%).Conclusions: Prehabilitation interventions showed mixed levels of effectiveness, and there is insufficient RCT evidence to suggest system‐level delivery across General Surgery within standardized protocols. However, given potential benefits and non‐inferiority to standard care, they should be considered on a case‐by‐case basis.
Aims: Artificial intelligence (AI) is having an increasing impact on many aspects of our day‐to‐day lives. This change is also true in healthcare, with various tools being developed to hasten burdensome administrative tasks and increase overall healthcare efficiency, particularly in metropolitan centres.Context: AI has remained comparatively clear of rural, regional and remote Australian hospitals, where it has the potential to provide significant benefits. Like previous health technology implementations, rural workforce requirements for AI maintenance and support may hinder AI deployment in these areas. While AI has been implemented successfully in metropolitan areas, these models may have limited translatability to rural health settings with significantly different administrative and healthcare systems.Approach: AI may assist with key issues in rural centres such as resource allocation and timely patient transfer for higher level care. While the potential benefits of AI in rural centres are clear, one must consider key factors in rural centres that may limit the success of AI in these hospitals. Smaller rural populations may limit the ability to train location‐specific models, and connectivity issues may impede their effective use.Conclusion: Specific efforts are required to realise potential benefits of medical AI for rural Australia; addressing connectivity and workforce issues in rural areas is vital to allow for AI and large language models to help benefit rural centres.
The efficacy of large language models (LLMs) in discharge summary preparation using real clinical documentation remains novel. Our study aimed to test the efficacy of two LLMs to generate DC summaries which were scored using a validated discharge summary scoring metric. The models performed nearly identically, with the llama3:instruct model having a mean score of 19.1/31 (SD: 2.42) compared to 19.2/31 (SD: 3.48) when produced by llama3:70b. Using LLMs to aid in the generation of discharge summaries may help to reduce the overall clinical administrative workload.
A retrospective review of 7185 South Australian discharge summaries revealed that 37.6% of discharge summaries were released at least a day after discharge, and per day of delay of medical discharge summary release, the chance of hospital 30‐day readmission increased by 1.60% (P < 0.001). Delays may be associated with the task being time‐consuming. The workforce impact of junior doctor time and increased readmission rates favours interventions to change discharge summary workflows.
19 September 2025 in Journal of Trauma and Acute Care Surgery
BACKGROUND: FIBTEM, a component of rotational thromboelastometry, assesses the functional contribution of fibrin to clot formation. Notably, impaired fibrin function using FIBTEM may be observed despite normal plasma fibrinogen levels measured by the Clauss assay. The clinical implications of such isolated functional deficits are poorly understood in traumatic intracranial hemorrhage (TICH) and are the focus of this brief report. METHODS: From February 2022 to July 2023, we conducted a single-center retrospective study of patients with TICH and Glasgow Coma Scale score of ≤14. All participants had paired FIBTEM and Clauss fibrinogen levels from simultaneously drawn samples. Patients were grouped as follows: (1) FIBTEM-A5 >10 mm, (2) FIBTEM-A5 ≤10 mm with Clauss fibrinogen >2 g/L (isolated fibrin dysfunction), and (3) FIBTEM-A5 ≤10 mm with fibrinogen ≤2 g/L (true fibrinogen deficiency [TD]). Rates of progressive hemorrhagic injury and mortality were compared using univariate and multivariable analyses. RESULTS: Of 73 included patients, 37 (51%) had reduced FIBTEM-A5; among these, 12 (32%) experienced TD. Mortality occurred in 7 of 12 TD patients (58%), 11 of 36 (31%) with FIBTEM-A5 >10 mm, and 6 of 25 (24%) with isolated fibrin dysfunction. Progressive hemorrhagic injury occurred in 6 of 9 TD patients (66%), 2 of 26 (8%) with FIBTEM-A5 >10 mm, and 9 of 23 (39%) with isolated fibrin dysfunction. In multivariate analysis, TD was associated with a 4.5-fold increase in the log odds of progressive hemorrhagic injury (95% confidence interval, 1.5–7.4), while isolated fibrin dysfunction was associated with a 3.2-fold increase (95% confidence interval, 1.0–5.4). No significant associations with mortality were observed. CONCLUSION: In TICH, low FIBTEM-A5 may reflect either fibrinogen deficiency or impaired fibrin function. Progressive hemorrhagic injury is increased in both of these phenotypes. Further research is needed to validate these findings and to guide the optimal clinical response to low FIBTEM-A5 in neurotrauma. LEVEL OF EVIDENCE: Prognostic and Epidemiologic; Level IV.
9 September 2025 in Ophthalmic Plastic & Reconstructive Surgery
Carotid-cavernous fistulas (CCF) are indirect or direct vascular shunts between vessels of the cavernous sinus and the carotid artery. While indirect CCFs have high rates of spontaneous resolution, direct CCF cases can result in significant orbital and neurological sequelae. This case describes a 75-year-old male patient presenting with acute subarachnoid hemorrhage secondary to a Barrow type-D CCF. Digital subtraction angiography revealed dual arterial supply of the CCF from both the left and right internal carotid artery. Transvenous access for coiling could not be achieved due to vessel tortuosity. Thus, the authors used an endoscopic transorbital approach to directly puncture the cavernous sinus through the superior orbital fissure. This approach allowed for direct visualization of the lateral cavernous sinus and enabled endovascular maneuvrability and coiling. There was a reduction but residual flow post CCF coiling due to microcatheter kickback preventing posterior embolization. Persistent CCF necessitated a craniotomy to allow sufficient access for complete obliteration. At 6-week postcoiling, there was resolution of proptosis and full extraocular movements. This approach has been described in cadaveric studies, with this case demonstrating the first application of this technique in vivo for CCF.